Abbott Laboratories Minority Interest

The latest minority interest for ABT is $650M as of June 2026. That compares with $260M in the prior-year period — up 147.0% year over year. Investors often review this figure alongside Abbott Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABT's minority interest moved from $260M to $650M — a 147.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abbott Laboratories's operating scale or balance-sheet position.

A minority interest figure of $650M for ABT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ABT's minority interest ($650M), review year-over-year change from $260M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Abbott Laboratories's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.